Venerando Randall Guelpa

DDS | Dentist



  
  4300 Bayou Blvd, Suite 6, Pensacola
  Florida, 32503-1949

  850-476-4849    Maps & Directions
Venerando Randall Guelpa is a Pensacola, Florida based Dentist who is specialized in General Practice Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 4300 Bayou Blvd, Suite 6, Pensacola. Patients can reach him at 850-476-4849.
Venerando Randall Guelpa is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Venerando Randall Guelpa speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Venerando Randall Guelpa
Specialization: Dentist
Gender:Male
Credentials: DDS
Accepts Medicare Assignment:May Accept
Practice Address:4300 Bayou Blvd, Suite 6, Pensacola,
Florida, 32503-1949
Phone:850-476-4849
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 7416268222
Enrollment ID: I20150622000009
NPI Number: 1225160328
NPI Enumeration Date: 12 Mar, 2007
NPI Last Update On: 08 Jul, 2007

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 4300 Bayou Blvd, Suite 6
Pensacola, Florida
Zip: 32503-1949
Patients can reach Venerando Randall Guelpa at 4300 Bayou Blvd, Suite 6, Pensacola, Florida or can call to book an appointment on 850-476-4849. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: